Table 1 Descriptive statistics of the study population with data on germline variants based on genome-wide association study and somatic mutations based on targeted tumor sequencing (n = 1375 colorectal cancer cases).

From: Association between germline variants and somatic mutations in colorectal cancer

 

Hypermutated

(N = 241)

Not Hypermutated

(N = 1134)

Overall

(N = 1375)

Sex

Female

141 (59%)

558 (49%)

699 (51%)

Male

100 (41%)

576 (51%)

676 (49%)

Age at diagnosis

Mean (SD)

64.0 (12.5)

61.0 (12.0)

61.6 (12.2)

Median [Min, Max]

66.0 [28.0, 90.0]

63.0 [21.0, 91.0]

63.0 [21.0, 91.0]

Study

CORSA

22 (9%)

84 (7%)

106 (8%)

CPSII

54 (22%)

164 (14%)

218 (16%)

OFCCR

91 (38%)

546 (48%)

637 (46%)

SFCCR

74 (31%)

340 (30%)

414 (30%)

Number non silent indel mutations

Mean (SD)

14.7 (11.3)

1.01 (1.40)

3.40 (7.14)

Median [Min, Max]

13.0 [0, 49.0]

1.00 [0, 14.0]

1.00 [0, 49.0]

Number non silent SNV mutations

Mean (SD)

36.5 (39.0)

4.72 (2.45)

10.3 (20.4)

Median [Min, Max]

26.0 [2.00, 334]

5.00 [0, 14.0]

5.00 [0, 334]

Number non silent indel and SNV Mutations

Mean (SD)

51.2 (39.0)

5.73 (3.03)

13.7 (23.9)

Median [Min, Max]

44.0 [2.00, 335]

5.00 [0, 24.0]

6.00 [0, 335]